Abiomed, Inc. reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was USD 265.92 million compared to USD 248.14 million a year ago. Net income was USD 106.13 million compared to USD 56.95 million a year ago. Basic earnings per share from continuing operations was USD 2.34 compared to USD 1.25 a year ago. Diluted earnings per share from continuing operations was USD 2.32 compared to USD 1.24 a year ago.
For the six months, sales was USD 543.07 million compared to USD 500.73 million a year ago. Net income was USD 160.69 million compared to USD 30.43 million a year ago. Basic earnings per share from continuing operations was USD 3.53 compared to USD 0.67 a year ago. Diluted earnings per share from continuing operations was USD 3.51 compared to USD 0.66 a year ago.